FDA Orange Book · active-ingredient family
Indium in-111 pentetreotide kit
Indium in-111 pentetreotide kit is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:OCTREOSCAN · NDA 020314
1
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| OCTREOSCANRLD | CURIUM | NDA 020314 | — | Jun 02, 1994 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| INDIUM IN-111 PENTETREOTIDE KIT | SUN PHARM INDS INC | ANDA 212785 | — | Jul 01, 2024 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Indium in-111 pentetreotide kit — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
